Publication: Trigeminal nerve stimulation: a recently approved treatment approach in attention deficit hyperactivity disorder
Program
KU-Authors
KU Authors
Co-Authors
Çöpür, Mazlum
Publication Date
Language
Type
Embargo Status
Journal Title
Journal ISSN
Volume Title
Alternative Title
Abstract
Attention-deficit hyperactivity disorder (ADHD) with its high prevalence is a growing area of concern and research, whereas exact underlying pathophysiology remains unknown. Behavioral therapy and multiple medications include methylphenidate, atomoxetine, and amphetamines while trigeminal nerve stimulator (TNS) is the first medical device in ADHD with FDA approval. The aim of this article is to evaluate the latest studies in this field.
Source
Publisher
Springer
Subject
Neurosciences
Citation
Has Part
Source
Egyptian Journal of Neurology Psychiatry and Neurosurgery
Book Series Title
Edition
DOI
10.1186/s41983-021-00353-w